Literature DB >> 12407617

Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery.

Christian von Heymann1, H Hotz, W Konertz, W J Kox, C Spies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12407617     DOI： 10.1053/jcan.2002.126927

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  6 in total

Review 1.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

2.  Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.

Authors:  Yoan Lamarche; Philippe Demers; Nancy C Poirier; Danielle Robitaille; Raymond Cartier
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

Review 3.  Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

Authors:  R Michael Grounds; Charles Bolan
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

4.  The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial.

Authors:  Narges Payani; Mahnoosh Foroughi; Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2015-02-01

5.  Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.

Authors:  Manish J Gandhi; Richard A Pierce; Lini Zhang; Marc R Moon; George J Despotis; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-07-06       Impact factor: 1.637

6.  Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.

Authors:  Joel T Feih; Janelle J Juul; Joseph R G Rinka; Lisa M Baumann Kreuziger; Paul S Pagel; Justin N Tawil
Journal:  Ann Card Anaesth       Date:  2019 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.